Italian study examines targeted radiation for rare gland tumors
NCT ID NCT07538791
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This study looks back at how well a type of targeted radiation therapy (PRRT) works for people with advanced pheochromocytoma and paraganglioma, rare tumors of the adrenal glands. Researchers will analyze data from about 210 patients treated in Italy over 24 years. The goal is to measure how often the disease is controlled and how long patients live after treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARAGANGLIOMAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Azienda Ospedaliero-Universitaria Policlinico di Modena
Modena, Italy
-
Azienda Ospedaliero-Universitaria di Ferrara
Ferrara, Italy
-
Azienda USL IRCCS di Reggio Emilia
Reggio Emilia, Italy
-
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Milan, Italy
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy
-
Irst Irccs
Meldola, Italy
-
Istituto Europeo di Oncologia
Milan, Italy
-
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale
Naples, Italy
-
Policlinico di Bari
Bari, Italy
-
Università degli Studi di Napoli Federico II
Naples, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.